πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Pipeline programs

Browse 12,558 clinical pipeline programs from ClinicalTrials.gov, linked to pharma companies. Phase, modality, and trial IDs for BD teams.

12,558 programs 407 companies
project

611

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

1 trials
project

611

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

3 trials
project

611

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

2 trials
project

68Ga-PSMA-11

China SXT Pharmaceuticals

Phase 3 Β· small_molecule Β· active

1 trials
project

68Ga-PSMA-11

Telix Pharmaceuticals Ltd

Phase 3 Β· small_molecule Β· active

1 trials
project

750 mg Imsidolimab

Vanda Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

1 trials
project

8 mg aflibercept (BAY 86-5321) (High Dose)

REGENERON PHARMACEUTICALS, INC.

Phase 3 Β· small_molecule Β· completed

1 trials
project

89Zr-Girentuximab

Telix Pharmaceuticals Ltd

Phase 3 Β· small_molecule Β· completed

2 trials
project

89Zr-TLX250 PET/CT

Telix Pharmaceuticals Ltd

Phase 3 Β· small_molecule Β· active

1 trials
project

9vHPV Vaccine

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· mab Β· completed

1 trials
project

A-101

Aclaris Therapeutics

Phase 3 Β· small_molecule Β· completed

2 trials
project

A-101 Solution

Aclaris Therapeutics

Phase 3 Β· small_molecule Β· completed

3 trials
project

ACP-204

ACADIA PHARMACEUTICALS INC

Phase 3 Β· small_molecule Β· active

2 trials
project

ACP-204

ACADIA PHARMACEUTICALS INC

Phase 3 Β· small_molecule Β· active

2 trials
project

ACR16

TEVA PHARMACEUTICAL INDUSTRIES LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

ACTIQ (Oral transmucosal fentanyl citrate)

TEVA PHARMACEUTICAL INDUSTRIES LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

AD04 (ondansetron)

ADIAL PHARMACEUTICALS, INC.

Phase 3 Β· small_molecule Β· completed

1 trials
project

ADX-102 1% Topical Dermal Cream (reproxalap)

Aldeyra Therapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

ADX-102 Ophthalmic Solution (0.5%)

Aldeyra Therapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

ADX-2191 (intravitreal methotrexate 0.8%)

Aldeyra Therapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

AG-348

AGIOS PHARMACEUTICALS, INC.

Phase 3 Β· small_molecule Β· completed

2 trials
project

AG10

BridgeBio Oncology Therapeutics

Phase 3 Β· small_molecule Β· terminated

1 trials
project

AK112 Injection

Summit Therapeutics

Phase 3 Β· small_molecule Β· active

1 trials
project

ALVAC-HIV vCP1521 + AIDSVAX

UNITED THERAPEUTICS Corp

Phase 3 Β· mab Β· completed

1 trials